Hereditary hemochromatosis
Zuletzt aktualisiert 3 Apr 2025
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Hereditary hemochromatosis is a disorder that causes the body to absorb too much iron from the diet. The excess iron is stored in the body's tissues and organs, particularly the skin, heart, liver, pancreas, and joints. Because humans cannot increase the excretion of iron, excess iron can overload and eventually damage tissues and organs. For this reason, hereditary hemochromatosis is also called an iron overload disorder.
Beschreibung
Hereditary hemochromatosis is a disorder that causes the body to absorb too much iron from the diet. The excess iron is stored in the body's tissues and organs, particularly the skin, heart, liver, pancreas, and joints. Because humans cannot increase the excretion of iron, excess iron can overload and eventually damage tissues and organs. For this reason, hereditary hemochromatosis is also called an iron overload disorder.
Early symptoms of hereditary hemochromatosis may include extreme tiredness (fatigue), joint pain, abdominal pain, weight loss, and loss of sex drive. As the condition worsens, affected individuals may develop arthritis, liver disease (cirrhosis) or liver cancer, diabetes, heart abnormalities, or skin discoloration. The appearance and severity of symptoms can be affected by environmental and lifestyle factors such as the amount of iron in the diet, alcohol use, and infections.
There are four types of hereditary hemochromatosis, which are classified depending on the age of onset and other factors such as genetic cause and mode of inheritance.
Type 1, the most common form of the disorder, and type 4 (also called ferroportin disease) begin in adulthood. Men with type 1 or type 4 hemochromatosis typically develop symptoms between the ages of 40 and 60, and women usually develop symptoms after menopause.
Type 2 hemochromatosis is known as a juvenile-onset disorder because symptoms often begin in childhood. By age 20, iron accumulation causes decreased or absent secretion of sex hormones. Affected females usually begin menstruation normally but menses stop after a few years. Males may experience delayed puberty or symptoms related to a shortage of sex hormones. If type 2 hemochromatosis is untreated, potentially fatal heart disease becomes evident by age 30.
The onset of type 3 hemochromatosis is usually intermediate between types 1 and 2 with symptoms generally beginning before age 30.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Bronze diabetes
Bronzed cirrhosis
Familial hemochromatosis
Genetic hemochromatosis
Hämochromatose
HC
Hemochromatosis
Hereditäre Hämochromatose
HH
HLAH
Iron storage disorder
Pigmentary cirrhosis
Primary hemochromatosis
Troisier-Hanot-Chauffard syndrome
Von Recklenhausen-Applebaum disease
Related patient information and medicines

Patient information leaflet
Leberzirrhose
Parasites are living things (organisms) that live withi... Severe heart failure which can cause back pressure of blood and congestion in the liver. Some rare inherited diseases which can cause damage to liver cells. Zum Beispiel: Haemochromatosis Haemochromatosis. This is a condition which causes an abnormal build-up of iron in the liver and other.

Patient information leaflet
Leberfunktionstests
You have an underlying condition that affects the liver's production and storage abilities (for example, Wilson's disease , haemochromatosis Haemochromatosis , Gilbert's syndrome Gilbert's syndrome ). Causes can include reactions to medicines, lifelong (congenital) blood cell abnormalities such as hereditary spherocytosis Hereditary spherocytosis.

Patient information leaflet
Porphyrie
Der porphyrias are a group of disorders in which there is a problem with the production of haem (also spelled heme) within the body. Haem ist used zur make haemoglobin in red blood cells. There are seven different types of Porphyrie and in most cases they läuft in Familien (are inherited). It is important that the type of porphyria that you have.

Patient information leaflet
Dilatative Kardiomyopathie
Another possibility is that an unknown viral infection may be responsible. About one in four people with idiopathic dilated Kardiomyopathie haben a familial (hereditary) form. This means that several members of their family also have dilated cardiomyopathy. It is still not clear exactly how hered... For example, dilated cardiomyopathy sometimes.

Patient information leaflet
Immunsuppression
Examples where this occurs and the spleen may need to be removed include: Immune thrombocytopenia. Immune thrombocytopenic purpura Hereditary spherocytosis. Hereditary spherocytosis Hereditary elliptocytosis. Lymphomas and leukaemias. See the separate leaflets called Spleen Pain and Preventing infection after Splenectomy Preventing infection after.

Patient information leaflet
Milzschmerzen
This leaflet gives a brief overview of the spleen and its functions. What is the spleen. Haemoglobin is a chemi... It is found within the cells and is also broken down and then recycled. See the separate leaflet called Hereditäre Sphärozytose as an example of a condition with abnormal red Blut cells Hereditary spherocytosis. It also stores up to.
Weiterführende Lektüre und Referenzen
- Hereditary hemochromatosis; MedlinePlus, National Library of Medicine.
- Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis. 2011 Aug;31(3):280-92. doi: 10.1055/s-0031-1286059. Epub 2011 Sep 7.
- Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330. No abstract available.
- Barton JC. Hemochromatosis and iron overload: from bench to clinic. Am J Med Sci. 2013 Nov;346(5):403-12. doi: 10.1097/MAJ.0000000000000192. No abstract available.
- Brissot P, Cavey T, Ropert M, Guggenbuhl P, Loreal O. Genetic hemochromatosis: Pathophysiology, diagnostic and therapeutic management. Presse Med. 2017 Dec;46(12 Pt 2):e288-e295. doi: 10.1016/j.lpm.2017.05.037. Epub 2017 Nov 20.
- Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000 May;25(1):14-5. doi: 10.1038/75534.
- Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013 Feb 1;87(3):183-90.
- Gerhard GS, Paynton BV, DiStefano JK. Identification of Genes for Hereditary Hemochromatosis. Methods Mol Biol. 2018;1706:353-365. doi: 10.1007/978-1-4939-7471-9_19.
- Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001 Aug;108(4):619-23. doi: 10.1172/JCI13468.
- Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001 Jul;28(3):213-4. doi: 10.1038/90038.
- Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010 Aug;139(2):393-408, 408.e1-2. doi: 10.1053/j.gastro.2010.06.013. Epub 2010 Jun 11.
- Porto G, Brissot P, Swinkels DW, Zoller H, Kamarainen O, Patton S, Alonso I, Morris M, Keeney S. EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). Eur J Hum Genet. 2016 Apr;24(4):479-95. doi: 10.1038/ejhg.2015.128. Epub 2015 Jul 8.
- Radford-Smith DE, Powell EE, Powell LW. Haemochromatosis: a clinical update for the practising physician. Intern Med J. 2018 May;48(5):509-516. doi: 10.1111/imj.13784.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
3 Apr 2025 | Neueste Version
1 Oct 2006 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

